| 摘要 |
FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to gynaecology, and can be used for the prediction of recurrent carcinoma of the vulva. To this effect, treatment is preceded by examining the patient's blood for large granular lymphocytes (LGLs) and circulating immune complexes (CICs). If the LGL level is more than 11.8%, and the CIC level is less than 33.3 standard units, a recurrence-free period for 5 years and more is predicted. If the LGL level is less than 9.8% and the CIC level is more than 42.7 standard units, a recurrence progression for the following 2 years is predicted.EFFECT: using the given method enables conducting the most effective therapeutic measures in the patients with unfavourable prognosis, as well as indicates a necessity of the regular careful case follow-up accompanied by the additive clinical-laboratory examinations.4 ex |
